Request for Cooperative Agreement Applications: RFA-NIH-NIAID

4

substantial NIH programmatic involvement with the recipient
organization, during the performance of the planned activity, is
anticipated.
NATIONAL COOPERATIVE VACCINE DEVELOPMENT GROUP (NCVDG) In this
RFA the terms, NATIONAL COOPERATIVE VACCINE DEVELOPMENT GROUP,
NCVDG, and "group" are synonymous. Each group may be composed of
a relatively large number of investigators from academic and/or
non-profit research institutions and scientists from commercial
organizations who are performing research on various research
projects.
RESEARCH PROJECT - A discrete, specified, circumscribed project
which must relate to the overall theme of the NCVDG.
PROJECT LEADER - The Director of one of the scientific research
projects of the NCVDG.
PRINCIPAL INVESTIGATOR - The person who assembles the NCVDG,
submits the single application in response to this RFA and who is
responsible for the performance of the Group as a whole and each
of the Project Leaders. The Principal Investigator may lead one
of the Research Projects of the Group and coordinate Group
activities scientifically and administratively. The Principal
Investigator's institution establishes and operates the Central
Operations Office that funds Group members and is legally and
fiscally accountable for the disposition of funds awarded.
NIAID SCIENTIFIC COORDINATOR - A member of the extramural staff
of the.NIAID who functions as a peer with the Principal
Investigators and Project Leaders and facilitates the partnership
relationship between NIAID and the Groups.
INVENTION - A new vaccine that is or may be patentable under
Title 35 of the United States Code.
ARBITRATION PANEL - A group composed of the Principal
Investigator or Project Leader of a particular NCVDG as the
"group" designee, one NIAID designee, and a third designee with
expertise in the relevant area and chosen by the other two. Such
panels may help resolve both scientific and administrative issues
that develop during the course of work and restrict progress.
V. COMPOSITION
A. The composition of a NCVDG is envisioned as follows:
1. Principal Investigator;
2. Project Leaders, each heading a research project. The
research projects will utilize diverse scientific
disciplines that are appropriate to the realization of Group
objectives (e.g. virology, humoral immunology, cellular
immunology, biochemistry, structural chemistry,